HK Stock MarketDetailed Quotes

03320 CHINARES PHARMA

Watchlist
  • 4.860
  • +0.100+2.10%
Noon Break Apr 24 11:59 CST
30.53BMarket Cap7.18P/E (TTM)

CHINARES PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
12.16%244.7B
10.52%138.94B
-7.86%218.18B
9.81%125.72B
18.15%236.81B
28.08%114.49B
-1.97%200.42B
-12.30%89.39B
7.78%204.45B
8.73%101.92B
Operating income
12.16%244.7B
10.52%138.94B
-7.86%218.18B
9.81%125.72B
18.15%236.81B
28.08%114.49B
-1.97%200.42B
-12.30%89.39B
7.78%204.45B
8.73%101.92B
Cost of sales
-11.81%-206.37B
-10.12%-116.6B
8.37%-184.56B
-9.13%-105.88B
-19.80%-201.43B
-30.20%-97.02B
1.35%-168.13B
11.80%-74.52B
-10.13%-170.44B
-9.93%-84.49B
Operating expenses
-11.81%-206.37B
-10.12%-116.6B
8.37%-184.56B
-9.13%-105.88B
-19.80%-201.43B
-30.20%-97.02B
1.35%-168.13B
11.80%-74.52B
-10.13%-170.44B
-9.93%-84.49B
Gross profit
14.04%38.34B
12.65%22.34B
-4.98%33.62B
13.55%19.83B
9.56%35.38B
17.48%17.47B
-5.07%32.29B
-14.72%14.87B
-2.61%34.02B
3.27%17.43B
Selling expenses
-15.34%-18.91B
-14.97%-10.44B
6.48%-16.4B
-9.59%-9.08B
-9.37%-17.53B
-22.35%-8.28B
16.46%-16.03B
24.06%-6.77B
-4.62%-19.19B
-5.62%-8.91B
Administrative expenses
-13.44%-6.33B
-9.54%-3.21B
10.55%-5.58B
-8.58%-2.93B
-12.07%-6.24B
-25.74%-2.7B
-6.93%-5.56B
8.28%-2.15B
-8.56%-5.2B
-9.44%-2.34B
Operating interest expense
----
-18.38%-1.61B
----
7.39%-1.36B
12.96%-2.74B
5.32%-1.47B
15.06%-3.15B
---1.55B
---3.71B
----
Special items of operating profit
2.47%-1.84B
-218.64%-201.85M
-143.49%-1.88B
-540.76%-63.35M
-14.13%-773.81M
-28.30%14.37M
-215.67%-677.99M
-97.90%20.05M
140.42%586.15M
2,868.46%954M
Operating profit
15.37%11.26B
7.52%6.88B
20.58%9.76B
27.31%6.4B
17.85%8.09B
13.80%5.02B
5.69%6.87B
-38.10%4.41B
-46.02%6.5B
12.60%7.13B
Financing income
-18.51%587.69M
----
--721.18M
----
----
----
----
----
----
--326.1M
Financing cost
2.74%-2.39B
----
---2.45B
----
----
----
----
----
----
-32.81%-1.72B
Share of profits of associates
25.51%417.11M
29.35%240.48M
5.98%332.34M
30.26%185.91M
51.60%313.6M
89.37%142.73M
47.31%206.85M
11.51%75.37M
82.64%140.42M
-3.40%67.59M
Earning before tax
18.17%9.88B
8.14%7.12B
-0.56%8.36B
27.39%6.58B
18.84%8.41B
15.07%5.17B
6.57%7.08B
-22.70%4.49B
-27.69%6.64B
13.65%5.81B
Tax
-23.61%-2.11B
-0.77%-1.42B
3.29%-1.7B
-31.85%-1.41B
-0.52%-1.76B
-27.28%-1.07B
-13.63%-1.75B
25.16%-841.83M
4.25%-1.54B
-7.36%-1.12B
After-tax profit from continuing operations
16.78%7.78B
10.15%5.69B
0.16%6.66B
26.23%5.17B
24.87%6.65B
12.25%4.09B
4.43%5.32B
-22.11%3.65B
-32.68%5.1B
15.27%4.68B
Earning after tax
16.78%7.78B
10.15%5.69B
0.16%6.66B
26.23%5.17B
24.87%6.65B
12.25%4.09B
4.43%5.32B
-22.11%3.65B
-32.68%5.1B
15.27%4.68B
Minority profit
24.17%3.92B
23.88%2.66B
9.70%3.16B
29.40%2.14B
42.04%2.88B
54.71%1.66B
11.88%2.03B
-35.03%1.07B
-49.61%1.81B
-9.11%1.65B
Profit attributable to shareholders
10.11%3.85B
0.43%3.04B
-7.13%3.5B
24.07%3.03B
14.31%3.77B
-5.40%2.44B
0.33%3.3B
-15.09%2.58B
-17.38%3.29B
34.93%3.04B
Basic earnings per share
8.93%0.61
0.00%0.48
-6.67%0.56
23.08%0.48
15.38%0.6
-4.88%0.39
0.00%0.52
-14.58%0.41
-17.46%0.52
33.33%0.48
Diluted earnings per share
8.93%0.61
0.00%0.48
-6.67%0.56
23.08%0.48
15.38%0.6
-4.88%0.39
0.00%0.52
-14.58%0.41
-17.46%0.52
33.33%0.48
Currency Unit
CNY
HKD
CNY
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 12.16%244.7B10.52%138.94B-7.86%218.18B9.81%125.72B18.15%236.81B28.08%114.49B-1.97%200.42B-12.30%89.39B7.78%204.45B8.73%101.92B
Operating income 12.16%244.7B10.52%138.94B-7.86%218.18B9.81%125.72B18.15%236.81B28.08%114.49B-1.97%200.42B-12.30%89.39B7.78%204.45B8.73%101.92B
Cost of sales -11.81%-206.37B-10.12%-116.6B8.37%-184.56B-9.13%-105.88B-19.80%-201.43B-30.20%-97.02B1.35%-168.13B11.80%-74.52B-10.13%-170.44B-9.93%-84.49B
Operating expenses -11.81%-206.37B-10.12%-116.6B8.37%-184.56B-9.13%-105.88B-19.80%-201.43B-30.20%-97.02B1.35%-168.13B11.80%-74.52B-10.13%-170.44B-9.93%-84.49B
Gross profit 14.04%38.34B12.65%22.34B-4.98%33.62B13.55%19.83B9.56%35.38B17.48%17.47B-5.07%32.29B-14.72%14.87B-2.61%34.02B3.27%17.43B
Selling expenses -15.34%-18.91B-14.97%-10.44B6.48%-16.4B-9.59%-9.08B-9.37%-17.53B-22.35%-8.28B16.46%-16.03B24.06%-6.77B-4.62%-19.19B-5.62%-8.91B
Administrative expenses -13.44%-6.33B-9.54%-3.21B10.55%-5.58B-8.58%-2.93B-12.07%-6.24B-25.74%-2.7B-6.93%-5.56B8.28%-2.15B-8.56%-5.2B-9.44%-2.34B
Operating interest expense -----18.38%-1.61B----7.39%-1.36B12.96%-2.74B5.32%-1.47B15.06%-3.15B---1.55B---3.71B----
Special items of operating profit 2.47%-1.84B-218.64%-201.85M-143.49%-1.88B-540.76%-63.35M-14.13%-773.81M-28.30%14.37M-215.67%-677.99M-97.90%20.05M140.42%586.15M2,868.46%954M
Operating profit 15.37%11.26B7.52%6.88B20.58%9.76B27.31%6.4B17.85%8.09B13.80%5.02B5.69%6.87B-38.10%4.41B-46.02%6.5B12.60%7.13B
Financing income -18.51%587.69M------721.18M--------------------------326.1M
Financing cost 2.74%-2.39B-------2.45B-------------------------32.81%-1.72B
Share of profits of associates 25.51%417.11M29.35%240.48M5.98%332.34M30.26%185.91M51.60%313.6M89.37%142.73M47.31%206.85M11.51%75.37M82.64%140.42M-3.40%67.59M
Earning before tax 18.17%9.88B8.14%7.12B-0.56%8.36B27.39%6.58B18.84%8.41B15.07%5.17B6.57%7.08B-22.70%4.49B-27.69%6.64B13.65%5.81B
Tax -23.61%-2.11B-0.77%-1.42B3.29%-1.7B-31.85%-1.41B-0.52%-1.76B-27.28%-1.07B-13.63%-1.75B25.16%-841.83M4.25%-1.54B-7.36%-1.12B
After-tax profit from continuing operations 16.78%7.78B10.15%5.69B0.16%6.66B26.23%5.17B24.87%6.65B12.25%4.09B4.43%5.32B-22.11%3.65B-32.68%5.1B15.27%4.68B
Earning after tax 16.78%7.78B10.15%5.69B0.16%6.66B26.23%5.17B24.87%6.65B12.25%4.09B4.43%5.32B-22.11%3.65B-32.68%5.1B15.27%4.68B
Minority profit 24.17%3.92B23.88%2.66B9.70%3.16B29.40%2.14B42.04%2.88B54.71%1.66B11.88%2.03B-35.03%1.07B-49.61%1.81B-9.11%1.65B
Profit attributable to shareholders 10.11%3.85B0.43%3.04B-7.13%3.5B24.07%3.03B14.31%3.77B-5.40%2.44B0.33%3.3B-15.09%2.58B-17.38%3.29B34.93%3.04B
Basic earnings per share 8.93%0.610.00%0.48-6.67%0.5623.08%0.4815.38%0.6-4.88%0.390.00%0.52-14.58%0.41-17.46%0.5233.33%0.48
Diluted earnings per share 8.93%0.610.00%0.48-6.67%0.5623.08%0.4815.38%0.6-4.88%0.390.00%0.52-14.58%0.41-17.46%0.5233.33%0.48
Currency Unit CNYHKDCNYHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg